Adirondack Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Adirondack Trust CO

$244 Million
Q2 2024

A detailed history of Adirondack Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 421 shares of REGN stock, worth $437,953. This represents 0.18% of its overall portfolio holdings.

Number of Shares

421

Previous 422 0.24%

Holding current value

$437,953

Previous $406,000 8.87%

% of portfolio

0.18%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$883.2 - $1071.19 $883 - $1,071	-1 Reduced 0.24%	421 $442,000
Q1 2024 Apr 09, 2024	SELL	$902.69 - $993.35 $14,443 - $15,893	-16 Reduced 3.65%	422 $406,000
Q4 2023 Mar 29, 2024	SELL	$775.18 - $881.7 $17,053 - $19,397	-22 Reduced 4.78%	438 $384,000
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $7,000 - $8,303	-10 Reduced 2.13%	460 $330,000
Q1 2023 Apr 28, 2023	SELL	$680.49 - $826.97 $4,763 - $5,788	-7 Reduced 1.47%	470 $386,000
Q3 2022 Oct 13, 2022	BUY	$573.97 - $724.32 $15,497 - $19,556	27 Added 6.0%	477 $329,000
Q2 2022 Jul 06, 2022	BUY	$548.35 - $738.84 $31,255 - $42,113	57 Added 14.5%	450 $266,000
Q1 2022 Apr 05, 2022	BUY	$595.12 - $698.43 $75,580 - $88,700	127 Added 47.74%	393 $274,000
Q4 2021 Jan 13, 2022	BUY	$543.48 - $670.97 $2,173 - $2,683	4 Added 1.53%	266 $168,000
Q3 2021 Nov 16, 2021	BUY	$574.03 - $680.96 $6,314 - $7,490	11 Added 4.38%	262 $168,000
Q1 2021 Apr 16, 2021	BUY	$446.73 - $548.2 $62,542 - $76,748	140 Added 126.13%	251 $119,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1,434 - $1,823	3 Added 2.78%	111 $56,000
Q1 2020 Apr 23, 2020	BUY	$336.18 - $494.43 $1,680 - $2,472	5 Added 4.85%	108 $53,000
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $7,675 - $10,542	-28 Reduced 21.37%	103 $35,000
Q4 2018 Jan 18, 2019	SELL	$335.82 - $403.04 $3,022 - $3,627	-9 Reduced 6.43%	131 $49,000
Q3 2018 Oct 22, 2018	BUY	$351.14 - $408.51 $1,755 - $2,042	5 Added 3.7%	140 $57,000
Q1 2018 May 03, 2018	BUY	$315.82 - $393.78 $11,053 - $13,782	35 Added 35.0%	135 $41,000
Q3 2017 Oct 12, 2017	BUY	$431.38 - $504.0 $43,138 - $50,400	100	100 $45,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Account

Adirondack Trust CO Regeneron Pharmaceuticals, Inc. Transaction History